Success Metrics

Clinical Success Rate
66.7%

Based on 6 completed trials

Completion Rate
67%(6/9)
Active Trials
1(8%)
Results Posted
67%(4 trials)
Terminated
3(23%)

Phase Distribution

Ph phase_2
4
31%
Ph not_applicable
2
15%
Ph phase_3
3
23%
Ph phase_4
2
15%

Phase Distribution

0

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
3(27.3%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

54.5%

6 of 11 finished

Non-Completion Rate

45.5%

5 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(6)
Terminated(5)

Detailed Status

Completed6
Terminated3
Withdrawn2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (36.4%)
Phase 33 (27.3%)
Phase 42 (18.2%)
N/A2 (18.2%)

Trials by Status

recruiting18%
terminated323%
not_yet_recruiting18%
withdrawn215%
completed646%

Recent Activity

1 active trials
Showing 5 of 13
terminatedphase_4

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

NCT04973007
recruitingphase_4

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

NCT04373564
withdrawnphase_2

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

NCT04910425
completedphase_2

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

NCT03703492
not_yet_recruitingphase_3

Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics

NCT06406517
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT04973007Phase 4

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

Terminated
NCT04373564Phase 4

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Recruiting
NCT04910425Phase 2

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Withdrawn
NCT03703492Phase 2

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

Completed
NCT06406517Phase 3

Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics

Not Yet Recruiting
NCT04132843Not Applicable

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

Completed
NCT02633501Phase 2

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Completed
NCT03091803

QSM and Regional DCE MRI Permeability Using GOCART Technique

Withdrawn
NCT01710254Phase 2

Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients

Completed
NCT02967380Not Applicable

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Terminated
NCT02291822

Retrospective Study of MRI in Pediatric Patients

Completed
NCT01260636Phase 3

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries

Completed
NCT00323310Phase 3

Safety and Efficacy of MultiHance in Pediatric Patients

Terminated

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13